Cancer Treatment

India needs a five-year policy agenda to make advanced genomic testing and targeted cancer therapies accessible to lower-income patients, leading oncologist Dr Bhawna Sirohi said on Saturday. Speaking to PTI, Sirohi noted that precision oncology has the potential to transform cancer treatment, but high costs, limited access to advanced genomic testing and expensive drugs remain major challenges in the country. Sirohi, consultant medical oncologist and medical director at Vedanta Medical Research Foundation-BALCO Medical Centre, Raipur, is the only cancer specialist from India on a new Lancet Oncology Commission on precision cancer, launched at the World Cancer Congress in Hong Kong on Friday. The cancer specialist stated that unlike conventional chemotherapy, which can affect both cancerous and normal cells, precision treatment seeks to identify a specific target or biomarker on cancer cells and match it with an appropriate drug. Precision oncology allows doctors to identify the ..

Bengaluru company expects annual volumes to double as decentralised test lowers logistical barriers to personalised treatment

Combine a robust base health plan with a super top-up, critical illness cover and a dedicated medical corpus to protect household finances from soaring treatment costs

Clears way for higher rates for Cisplatin and Carboplatin amid supply crunch

An estimated 16% of expected cancer diagnoses across Australia, Canada, Denmark, Ireland, New Zealand, Norway and the UK were missing between April and December 2020, compared with pre-pandemic trends

Hospitals, diagnostics firms, and support groups are expanding cancer care into tier-2 and tier-3 cities as demand, screening and awareness rise beyond large metros

Rising capacity, cost advantage, and new centres position India as a key destination for advanced cancer care, though access gaps and affordability remain challenges

The tumor was discovered during a routine check-up after surgery for an enlarged benign prostate a year and a half ago, he said

With cancer treatment costs rising, insurers are offering specialised plans that provide staged payouts, long-term financial protection and support across diagnosis and recovery

As cancer treatments improve survival, experts stress early fertility discussions and preservation options so patients can make informed choices about life after treatment

New research finds the thymus remains active in adults and may influence immunity, cancer outcomes and ageing risk, with stronger thymus function linked to better survival and lower disease burden

A new study shows that tweaking natural killer cells and briefly treating them with a cancer drug helped them destroy blood cancer cells more effectively in lab and animal tests

AstraZeneca Pharma India Ltd on Tuesday said it has received permission from India's drug regulator to market Durvalumab solution for infusion used in cancer treatment for an additional indication. The company has received permission from the Central Drugs Standard Control Organisation, Directorate General of Health Services, to import for sale and distribution of Durvalumab solution for infusion of strengths 120 mg/2.4 ml and 500 mg/10 ml (brand name Imfinzi) for an additional indication, AstraZeneca Pharma said in a regulatory filing. Through this approval, Durvalumab in combination with carboplatin and paclitaxel is indicated for the first-line treatment of adults with primary advanced or recurrent endometrial cancer who are candidates for systemic therapy, followed by maintenance treatment with Durvalumab as monotherapy in endometrial cancer which is mismatch repair deficient (dMMR). The receipt of this permission paves way for the marketing of Durvalumab solution for infusion 1

Just 102 of the 297 day care cancer centres approved for FY26 are operational so far, with states such as Telangana, Bihar and Karnataka reporting a higher share of functional facilities

A machine learning study has flagged more than 260,000 cancer research papers worldwide as potentially linked to paper mills, raising serious concerns about the reliability and integrity of cancer sci

World Cancer Day 2026: Being declared cancer-free does not always mean full recovery, as oncologists explain why life after cancer often involves lasting physical, mental and emotional effects

World Cancer Day 2026 marks February 4 with the theme 'United by Unique', tracing the day's history and underlining why prevention, screening and equitable access to cancer care matter worldwide

Scientists in Spain have reported a promising pancreatic cancer breakthrough in mice, where a triple-drug therapy eliminated tumours by targeting the KRAS pathway, one of deadliest cancer mechanisms

A state-funded cancer research project centred on cow-based remedies has triggered debate. Surgical oncologist explains what science says, what evidence is missing, and why accountability matters

A string of CDSCO approvals and reviews is accelerating India's move to immunotherapies, ADCs and targeted drugs, widening options in major cancers and boosting competition